81 companies

Bod Science

Market Cap: AU$4.3m

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States.

BOD

AU$0.024

7D

0%

1Y

-65.2%

Patrys

Market Cap: AU$4.1m

Develops and commercializes antibody technologies for the treatment of cancer in Australia.

PAB

AU$0.002

7D

0%

1Y

-77.8%

Vectus Biosystems

Market Cap: AU$4.0m

Engages in the medical research and development activities in Australia.

VBS

AU$0.075

7D

0%

1Y

-73.2%

VGI Health Technology

Market Cap: AU$2.8m

VGI Health Technology Limited, a biotechnology company, engages in the research, development, distribution, and marketing of various health and therapeutic products, and technologies.

VTL

AU$0.02

7D

0%

1Y

n/a

Biotron

Market Cap: AU$2.7m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

BIT

AU$0.003

7D

-25.0%

1Y

-95.8%

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

HXL

AU$0.013

7D

0%

1Y

-18.8%

Anatara Lifesciences

Market Cap: AU$1.7m

Engages in the research, development, and commercialization of evidence-based solutions for gastrointestinal diseases in animals and humans in Australia.

ANR

AU$0.008

7D

-82.2%

1Y

-79.5%

Wellfully

Market Cap: AU$1.5m

Wellfully Limited, together with its subsidiaries, focuses on the development and commercialization of Dermaportation and ETP transdermal drug delivery technologies.

WFL

AU$0.003

7D

0%

1Y

-87.0%

BPH Global

Market Cap: AU$1.4m

Engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, China, and Southeast Asia.

BP8

AU$0.003

7D

-25.0%

1Y

-40.0%

Page 3 of 3